Hyperthyroidism Nutritional, Metabolic, Endocrine Hyperthyroidism
Conditions
Interventions
Recruitment took place in the province of Guangdong, China. Participants were randomised to the intervention and control groups in equal numbers.
Intervention group: Participants rece
Sponsors
Sun Yat-sen University (China)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Newly diagnosed hyperthyroid patients 2. No previous thyroid treatment 3. Elevated levels of a recent set of general serum and thyroid function tests, indication of hyperthyroidism 4. 24-hour uptake of 131I >=40%
Exclusion criteria
Exclusion criteria: 1. Severe liver or kidney damage 2. Agranulocytosis 3. Pregnancy or lactation 4. Less than 8 years of age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The outcomes above were assessed at monthly follow-up visits during the first year and then every 3 to 6 months thereafter. Duration of follow-up was 98.4 +/- 5.5 months (range: 89 - 108 months) for participants who were included in both primary and secondary outcomes measures. 1. Euthyroidism 2. Persistent hyperthyroidism 3. Recurrence 4. Clinical hypothyroidism 5. Sbclinical Hypothyroidism | — |
Secondary
| Measure | Time frame |
|---|---|
| The outcomes above were assessed at monthly follow-up visits during the first year and then every 3 to 6 months thereafter. Duration of follow-up was 98.4 +/- 5.5 months (range: 89 - 108 months) for participants who were included in both primary and secondary outcomes measures. 1. Changes in ophthalmopathy and complications 2. Side effects 3. Safety 4. Efficacy | — |
Countries
China
Outcome results
None listed